Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ansbacher, L. E.
Right arrow Articles by Cancilla, P. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ansbacher, L. E.
Right arrow Articles by Cancilla, P. A.
NEUROLOGY 1982;32:424
© 1982 American Academy of Neurology

Disulfiram neuropathy

A neurofilamentous distal axonopathy

Linda E. Ansbacher, M.D., E. Peter Bosch, M.D. and Pasquale A. Cancilla, M.D.

Department of Pathology (Dr. Ansbacher), University of Missouri, Columbia, MO, and the Departments of Pathology (Neuropathology) and Neurology (Drs. Bosch and Cancilla), University of Iowa Hospital and Clinics, Iowa City, IA.

Disulfiram is used to treat alcoholism and is known to cause peripheral neuropathy; few reports of biopsied human nerves have revealed axonal degeneration and loss of myelinated fibers. We studied a 22-year-old woman with severe sensorimotor neuropathy following treatment with disulfiram for 6 months. Histologic studies of the sural nerve revealed a neurofilamentous axonopathy with rare enlarged axons distended by neurofilaments. Disulfiram is converted enzymatically to carbon disulfide, which causes neurofilamentous distal axonopathy in animals. Similar changes in human nerve after disulfiram administration suggest that carbon disulfide is the toxic agent.

Address correspondence and reprint requests to Dr. Ansbacher, Department of Pathology, University of Missouri Hospital and Clinics, Columbia, MO 65212.

This investigation was supported by Grant R25 CA 180105 from the National Cancer Institute, Department of Health, Education and Welfare.

Presented in part at the thirty-third annual meeting of the American Academy of Neurology, Toronto, Ontario, April 1981.

Accepted for publication September 2, 1981.




This article has been cited by other articles:


Home page
Toxicol SciHome page
E. G. Tonkin, H. L. Valentine, D. M. Milatovic, and W. M. Valentine
N,N-Diethyldithiocarbamate Produces Copper Accumulation, Lipid Peroxidation, and Myelin Injury in Rat Peripheral Nerve
Toxicol. Sci., September 1, 2004; 81(1): 160 - 171.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1982 by AAN Enterprises, Inc.